Additionally, we performed further analysis of the xenograft GBM tumour tissues using HE and immunohistochemistry staining, which revealed that the expression of Ki‐67 and EN2 in the tumour tissues was observably reduced (Figure 3D). The gene discussed is MKI67; the disease is glioblastoma.